0000010795
2007-10-01
2008-09-30
0000010795
2008-06-30
0000010795
2007-09-30
0000010795
2008-03-31
0000010795
2009-04-01
2009-06-30
0000010795
2008-04-01
2008-06-30
0000010795
2007-10-01
2008-06-30
0000010795
2009-06-30
0000010795
2008-09-30
0000010795
2008-10-01
2009-06-30
iso4217:USD
xbrli:shares
xbrli:shares
iso4217:USD
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 1 - us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl,ns -->
<div align="center" style="font-size: 10pt; margin-top: 0pt"></div>
<div align="left">
</div>
<div align="center" style="font-size: 10pt; margin-top: 0pt">
</div>
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 1 — Basis of Presentation</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The accompanying unaudited condensed consolidated financial statements have been prepared in
accordance with the instructions to Form 10-Q and, in the opinion of the management of the Company,
include all adjustments which are of a normal recurring nature, necessary for a fair presentation
of the financial position and the results of operations and cash flows for the periods presented.
However, the financial statements do not include all information and footnotes required for a
presentation in accordance with U.S. generally accepted accounting principles. These condensed
consolidated financial statements should be read in conjunction with the consolidated financial
statements and the notes thereto included or incorporated by reference in the Company’s 2008 Annual
Report on Form 10-K. The results of operations for the interim periods are not necessarily
indicative of the results of operations to be expected for the full year.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company evaluates subsequent events and the evidence they provide about conditions existing at
the date of the balance sheet as well as conditions that arose after the balance sheet date but
before the financial statements are issued. The effects of conditions that existed at the date of
the balance sheet date are recognized in the financial statements. Events and conditions arising
after the balance sheet date but before the financial statements are issued are evaluated to
determine if disclosure is required to keep the financial statements from being misleading. To the
extent such events and conditions exist, disclosures are made regarding the nature of events and
the estimated financial effects for those events and conditions. For purposes of preparing the
accompanying condensed consolidated financial statements and the following notes to these financial
statements, the Company evaluated subsequent events through the date the financial statements were
issued.
</div>
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 2 - us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 2 — Accounting Change</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In June 2009, the Financial Accounting Standards Board (the “FASB”) issued Statement of Financial
Accounting Standards (“SFAS”) No. 168, “The FASB Accounting Standards Codification™ and the
Hierarchy of Generally Accepted Accounting Principles a Replacement of FASB Statement No. 162”
(“SFAS No. 168”). This Standard establishes the FASB Accounting Standards Codification™ (the
“Codification”) as the official source of authoritative GAAP (other than guidance issued by the
SEC) for all non-governmental entities. The Codification, which changes the referencing of
financial standards, supersedes current authoritative guidance and is effective for interim or
annual financial periods ending after September 15, 2009. The Codification is not intended to
change or alter existing GAAP and it is not expected to result in a change in accounting practice
for the Company.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In May 2009, the FASB issued SFAS No. 165, “Subsequent Events” (“SFAS No. 165”). SFAS No. 165
establishes general standards of accounting for and disclosure of events that occur after the
balance sheet date but before the financial statements are issued or are available to be issued.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company adopted SFAS No. 165 on June 30, 2009. SFAS No. 165 did not impact the consolidated
financial statements as a result of its adoption. The disclosures required under SFAS No. 165 are
included in Note 1.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In April 2009, the FASB issued FASB Staff Position (“FSP”) FAS 107-1 and APB 28-1, “Interim
Disclosures about Fair Value of Financial Instruments” (“FSP 107-1”), which amends SFAS No. 107,
“Fair Value Disclosures about Financial Instruments” (“SFAS No. 107”) to require disclosure about
fair value of financial instruments, including those not recognized on the statement of financial
position at fair value, for interim reporting periods as well as in annual financial statements.
The FSP is effective for interim and annual reporting periods ending after June 15, 2009. The
Company’s adoption of FSP 107-1 on June 30, 2009 did not impact the consolidated financial
statements. The disclosures required under FSP 107-1 are included in Note 12.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging
Activities-an amendment of FASB Statement No. 133” (“SFAS No. 161”). SFAS No. 161 amends and
expands the disclosure requirements of SFAS No. 133, “Accounting for Derivative Instruments and
Hedging Activities” (“SFAS No. 133”). The Statement requires qualitative disclosures regarding how
and why an entity uses derivative instruments as well as how these instruments and related hedged
items are accounted for under SFAS No. 133 and its related interpretations. Entities are also
required to provide tabular disclosures that quantify the effects derivative instruments and hedged
items have on financial position, financial performance, and cash flows. The Company adopted SFAS
No. 161 on March 31, 2009. SFAS No. 161 is a disclosure-only standard and, as such, did not impact
the consolidated financial statements as a result of its adoption. The disclosures required under
SFAS No. 161 are included in Note 11.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS No. 157”). SFAS
No. 157 defines fair value, establishes a framework for measuring fair value in GAAP, and expands
disclosures relating to fair value measurements. In February 2008, the FASB deferred
implementation of SFAS No. 157 for nonfinancial assets and nonfinancial liabilities not measured at
fair value on a recurring basis (at least annually) for one year. The Company implemented SFAS No.
157 for financial assets and liabilities, as well as other assets measured at fair value on a
recurring basis, on October 1, 2008. The effect of this adoption did not materially impact the
Company’s consolidated financial statements. The disclosures required under SFAS No. 157 are
included in Note 12. The Company is assessing the impact of adopting SFAS No. 157 on October 1,
2009 for nonfinancial assets and liabilities measured on a nonrecurring basis.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 3 - us-gaap:ComprehensiveIncomeNoteTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 3 — Comprehensive Income</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Comprehensive income was comprised of the following:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Net Income
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">341,027</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">297,089</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">914,383</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">844,821</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Other Comprehensive Income (Loss),
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Net of Tax
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:45px; text-indent:-15px">Foreign currency translation
adjustments
</div></td>
<td> </td>
<td> </td>
<td align="right">180,430</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">15,731</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(103,564</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">215,935</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:45px; text-indent:-15px">Benefit plans adjustment
</div></td>
<td> </td>
<td> </td>
<td align="right">3,097</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">1,830</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">9,291</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">5,492</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:45px; text-indent:-15px">Unrealized losses on investments,
net of amounts reclassifed net
of amounts reclassified
</div></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(22</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(86</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(87</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(61</td>
<td nowrap="nowrap">)</td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:45px; text-indent:-15px">Unrealized (losses) gains on
cash flow
hedges, net of amounts realized
</div></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(43,330</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">6,904</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(48,427</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">8,696</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td align="right">140,175</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">24,379</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(142,787</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">230,062</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Comprehensive Income
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">481,202</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">321,468</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">771,596</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,074,883</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Unrealized losses or gains on investments and cash flow hedges in comprehensive income have
been adjusted to reflect any realized gains and recognized losses included in net income during the
three and nine months ended June 30, 2009 and 2008. The change in foreign currency translation
adjustments for the three months ended June 30, 2009 is attributable to a weaker U.S. dollar versus
European currencies. The change in foreign currency translation adjustments for the nine months
ended June 30, 2009 is primarily attributable to a stronger U.S. dollar versus European and Latin
American currencies at June 30, 2009, compared with a weaker U.S. Dollar against stronger European
currencies at June 30, 2008.
</div>
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 4 - us-gaap:EarningsPerShareTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 4 — Earnings per Share</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The weighted average common shares used in the computations of basic and diluted earnings per share
(shares in thousands) were as follows:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="5%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="5%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="5%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="7">Three Months Ended</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="7">Nine Months Ended</td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #000000">June 30,</td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000">2008</td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Average common shares outstanding
</div></td>
<td> </td>
<td> </td>
<td align="right">240,109</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">244,273</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">240,923</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">244,478</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Dilutive share equivalents from
share-based plans
</div></td>
<td> </td>
<td> </td>
<td align="right">5,587</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">7,375</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">6,160</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">8,466</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td> </td>
<td align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td> </td>
<td align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td> </td>
<td align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Average common and common equivalent
shares outstanding – assuming dilution
</div></td>
<td> </td>
<td> </td>
<td align="right">245,696</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">251,648</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">247,083</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">252,944</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td> </td>
<td align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td> </td>
<td align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td> </td>
<td align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 5 - us-gaap:CommitmentsAndContingenciesDisclosureTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 5 — Contingencies</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company is named as a defendant in five purported class action suits brought on behalf of
direct purchasers of the Company’s products, such as distributors, alleging that the Company
violated federal antitrust laws, resulting in the charging of higher prices for the Company’s
products to the plaintiff and other purported class members. The cases filed are as follows:
<i>Louisiana Wholesale Drug Company, Inc., et. al. vs. Becton Dickinson and Company </i>(Civil Action No.
05-1602, U.S. District Court, Newark, New Jersey), filed on March 25, 2005; <i>SAJ Distributors, Inc.
et. al. vs. Becton Dickinson & Co. </i>(Case 2:05-CV-04763-JD, U.S. District Court, Eastern District of
Pennsylvania), filed on September 6, 2005; <i>Dik Drug Company, et. al. vs. Becton, Dickinson and
Company </i>(Case No. 2:05-CV-04465, U.S. District Court, Newark, New Jersey), filed on September 12,
2005; <i>American Sales Company, Inc. et. al. vs. Becton, Dickinson & Co. </i>(Case No. 2:05-CV-05212-CRM,
U.S. District Court, Eastern District of Pennsylvania), filed on October 3, 2005; and <i>Park Surgical
Co. Inc. et. al. vs. Becton, Dickinson and Company </i>(Case 2:05-CV-05678- CMR, U.S. District Court,
Eastern District of Pennsylvania), filed on October 26, 2005. These actions have been consolidated
under the caption <i>“In re Hypodermic Products Antitrust Litigation.”</i>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company is also named as a defendant in four purported class action suits brought on behalf of
indirect purchasers of the Company’s products, alleging that the Company violated federal and state
antitrust laws, resulting in the charging of higher prices for the Company’s products to the
plaintiff and other purported class members. The cases filed are as follows: <i>Jabo’s Pharmacy, Inc.,
et. al. v. Becton Dickinson & Company </i>(Case No. 2:05-CV-00162, U.S. District Court, Greenville,
Tennessee), filed on June 7, 2005; <i>Drug Mart Tallman, Inc., et. al. v. Becton Dickinson and Company</i>
(Case No. 2:06-CV-00174, U.S. District Court, Newark, New Jersey), filed on January 17, 2006;
<i>Medstar v. Becton Dickinson </i>(Case No. 06-CV-03258-JLL (RJH), U.S. District Court, Newark, New
Jersey), filed on May 18, 2006; and <i>The Hebrew Home for the Aged at Riverdale v. Becton Dickinson
and Company </i>(Case No. 07-CV-2544, U.S. District Court, Southern District of New York), filed on
March 28, 2007. A fifth purported class action on behalf of indirect purchasers <i>International
Multiple Sclerosis Management Practice v. Becton Dickinson & Company </i>(Case No. 2:07-cv-10602, U.S.
District Court, Newark, New Jersey), filed on April 5, 2007 was voluntarily withdrawn by the
plaintiff.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The plaintiffs in each of the antitrust class action lawsuits seek monetary damages. All of the
antitrust class action lawsuits have been consolidated for pre-trial purposes in a Multi-District
Litigation (MDL) in Federal court in New Jersey.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">On April 27, 2009, the Company entered into a settlement agreement with the direct purchaser
plaintiffs in these actions. Under the terms of the settlement agreement, which is subject to
preliminary and final approval by the court following notice to potential class members, the
Company will pay $45,000 into a settlement fund in exchange for a release by all potential class
members of the direct purchaser claims related to the products and acts enumerated in the
Complaint, as well as a dismissal of the case with prejudice. The release would not cover potential
class members that affirmatively opt out of the settlement. No settlement has been reached to date
with the indirect purchaser plaintiffs in these cases, which will continue to the extent these
cases relate to their claims. On May 7, 2009, certain indirect purchaser plaintiffs in the
litigation, who are not parties to the settlement, filed a motion with the court seeking to enjoin
the consummation of the settlement agreement on the grounds that, among other things, the court had
not yet ruled on the issue of which plaintiffs have direct purchaser standing.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">On June 6, 2006, UltiMed, Inc., a Minnesota company, filed suit against the Company in the U.S.
District Court in Minneapolis, Minnesota (<i>UltiMed, Inc. v. Becton, Dickinson and Company</i>
(06CV2266)). The plaintiff alleged, among other things, that the Company excluded the plaintiff
from the market for home use insulin syringes by entering into anticompetitive contracts in
violation of federal and state antitrust laws. The plaintiff sought money damages and injunctive
relief. On January 6, 2009, the Company and UltiMed entered into a settlement agreement for this
matter. Under the terms of the settlement, the Company paid $750.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In June 2007, Retractable Technologies, Inc. (“RTI”) filed a complaint against the Company under
the caption <i>Retractable Technologies, Inc. vs. Becton Dickinson and Company </i>(Civil Action No.
2:07-cv-250, U.S. District Court, Eastern District of Texas). RTI alleges that the BD
Integra<sup style="font-size: 85%; vertical-align: text-top">TM</sup> syringes infringe patents licensed exclusively to RTI. In its complaint, RTI
also alleges that the Company engaged in false advertising with respect to certain of the Company’s
safety-engineered products in violation of the Lanham Act; acted to exclude RTI from various
product markets and to maintain its market share through, among other things, exclusionary
contracts in violation of state and federal antitrust laws; and engaged in unfair competition. In
January 2008, the court granted the Company’s motion to sever the patent and non-patent claims into
separate cases. The non-patent claims have been stayed, pending resolution of RTI’s patent claims.
The trial on the patent claims is currently scheduled to commence in October 2009. RTI seeks money
damages and injunctive relief. On April 1, 2008, RTI filed a complaint against BD under the caption
<i>Retractable Technologies, Inc. and Thomas J. Shaw v. Becton Dickinson and Company </i>(Civil Action
No.2:08-cv-141, U.S. District Court, Eastern District of Texas). RTI alleges that the BD
Integra<sup style="font-size: 85%; vertical-align: text-top">TM</sup> syringes infringe another patent licensed exclusively to RTI. RTI seeks money
damages and injunctive relief. On August 29, 2008, the court ordered the consolidation of these two
cases.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company, along with another manufacturer and several medical product distributors, is named as
a defendant in two product liability lawsuits relating to healthcare workers who allegedly
sustained accidental needlesticks, but have not become infected with any disease. Generally, these
actions allege that healthcare workers have sustained needlesticks using hollow-bore needle devices
manufactured by the Company and, as a result, require medical testing, counseling and/or treatment.
In some cases, these actions additionally allege that the healthcare workers have sustained mental
anguish. Plaintiffs seek money damages in all of these actions. The Company had previously been
named as a defendant in nine similar suits relating to healthcare workers who allegedly sustained
accidental needlesticks, each of which has either been dismissed with prejudice or voluntarily
withdrawn. Regarding the two pending suits:
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In Ohio, <i>Grant vs. Becton Dickinson et al. </i>(Case No. 98CVB075616, Franklin County Court), on
September 21, 2006, the Ohio Court of Appeals reversed the trial court’s grant of class
certification. The matter had been remanded to the trial court for a determination of whether the
class can be redefined. On March 6, 2009, the Company and the plaintiff entered into a settlement
agreement, pursuant to which the Company paid $600.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In South Carolina, a suit has been filed on behalf of an unspecified number of healthcare workers
seeking class action certification in state court under the caption <i>Bales vs. Becton Dickinson et.
al. </i>(Case No. 98-CP-40- 4343, Richland County Court of Common Pleas), filed on November 25, 1998.
The Company continues to oppose class action certification in this case, including pursuing all
appropriate rights of appeal.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company, along with a number of other manufacturers, was named as a defendant in approximately
524 product liability lawsuits in various state and Federal courts related to natural
rubber latex gloves which the Company ceased manufacturing in 1995. Cases pending in Federal court
are being coordinated under the matter <i>In re Latex Gloves Products Liability Litigation </i>(MDL Docket
No. 1148) in Philadelphia, and analogous procedures have been implemented in the state courts of
California, Pennsylvania, New Jersey and New York. Generally, these actions allege that medical
personnel have suffered allergic reactions ranging from skin irritation to anaphylaxis as a result
of exposure to medical gloves containing natural rubber latex. Since the inception of this
litigation, 468 of these cases have been closed with no liability to the Company, and 46 cases have
been settled for an aggregate de minimis amount.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">On May 28, 2004, Therasense, Inc. (“Therasense”) filed suit against the Company (<i>Therasense, Inc.
and Abbott Laboratories v. Nova Biomedical Corporation and Becton, Dickinson and Company </i>(Case
Number: C 04-02123 WDA, U.S. District Court, Northern District of California)) asserting that the
Company’s blood glucose monitoring products (a product line no longer sold by the Company) infringe
four Therasense patents and seeking money damages. On August 10, 2004, in response to a motion
filed by Therasense in the U.S. District Court for the District of Massachusetts, the court
transferred to the court in California an action previously filed by the Company against Therasense
requesting a declaratory judgment that the Company’s products do not infringe the Therasense
patents and that the Therasense patents are invalid. On April 4, 2008, the Court granted the
Company summary judgment with respect to two of the patents asserted against the Company, finding
no infringement by the Company. On June 24, 2008, the Court ruled that a third patent asserted
against the Company was invalid and unenforceable. On August 8, 2008, a jury delivered a verdict in
the Company’s favor, finding that the last of the four patents asserted against the Company was
invalid. The plaintiffs have appealed these decisions.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">On September 19, 2007, the Company was served with a qui tam complaint filed by a private party
against the Company in the United States District Court, Northern District of Texas, alleging
violations of the Federal False Claims Act (“FCA”) and the Texas False Claims Act (the “TFCA”)
(<i>U.S. ex rel Fitzgerald v. BD et al. </i>(Civil Action No. 3:03-CV-1589, U.S. District Court, Northern
District of Texas). The suit alleges that a group purchasing organization’s practices with its
suppliers, including the Company, inflated the costs of healthcare reimbursement. Under the FCA,
the United States Department of Justice, Civil Division has a certain period of time in which to
decide whether to join the claim against the Company as an additional plaintiff; if it does not,
the private plaintiff is free to pursue the claim on its own. A similar process is followed under
the TFCA. To the Company’s knowledge, no decision has yet been made by the Civil Division or the
State of Texas whether to join this claim. In September 2008, the Court dismissed certain of the
plaintiff’s claims, but denied the Company’s motion to dismiss with respect to other claims.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company believes that it has meritorious defenses to each of the above-mentioned suits pending
against the Company and is engaged in a vigorous defense of each of these matters.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and
claims that arise in the ordinary course of business.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company is a party to a number of Federal proceedings in the United States brought under the
Comprehensive Environment Response, Compensation and Liability Act, also known as “Superfund,” and
similar state laws. The affected sites are in varying stages of development. In
some instances, the remedy has been completed, while in others, environmental studies are
commencing. For all sites, there are other potentially responsible parties that may be jointly or
severally liable to pay all cleanup costs.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Given the uncertain nature of litigation generally, the Company is not able in all cases to
estimate the amount or range of loss that could result from an unfavorable outcome of the
litigation to which the Company is a party. In accordance with U.S. generally accepted accounting
principles, the Company establishes accruals to the extent probable future losses are estimable (in
the case of environmental matters, without considering possible third-party recoveries). In view of
the uncertainties discussed above, the Company could incur charges in excess of any currently
established accruals and, to the extent available, excess liability insurance. In the opinion of
management, any such future charges, individually or in the aggregate, could have a material
adverse effect on the Company’s consolidated results of operations and consolidated cash flows.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 6 - us-gaap:SegmentReportingDisclosureTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 6 — Segment Data</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company’s organizational structure is based upon its three principal business segments: BD
Medical (“Medical”), BD Diagnostics (“Diagnostics”), and BD Biosciences (“Biosciences”). The
Company evaluates segment performance based upon operating income. Segment operating income
represents revenues reduced by product costs and operating expenses. The Company hedges against
certain forecasted sales of U.S.-produced products sold outside the United States. Gains and
losses associated with these foreign currency translation hedges are reported in segment revenues
based upon their proportionate share of these international sales of U.S.-produced products.
Financial information for the Company’s segments was as follows:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Revenues <i>(A)</i>
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Medical
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">968,671</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">998,148</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">2,725,347</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">2,790,439</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Diagnostics
</div></td>
<td> </td>
<td> </td>
<td align="right">566,379</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">553,422</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">1,646,211</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">1,606,745</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Biosciences
</div></td>
<td> </td>
<td> </td>
<td align="right">285,205</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">297,769</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">891,583</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">865,602</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">1,820,255</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,849,339</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">5,263,141</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">5,262,786</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Segment Operating Income
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Medical
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">303,663</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">283,904</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">811,111</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">791,088</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Diagnostics
</div></td>
<td> </td>
<td> </td>
<td align="right">154,836</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">135,443</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">450,637</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">387,744</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Biosciences
</div></td>
<td> </td>
<td> </td>
<td align="right">76,176</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">82,832</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">268,012</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">245,501</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:45px; text-indent:-15px">Total Segment
Operating Income
</div></td>
<td> </td>
<td> </td>
<td align="right">534,675</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">502,179</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">1,529,760</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">1,424,333</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Unallocated Items <i>(B)</i>
</div></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(105,680</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(93,309</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(327,430)</td>
<td nowrap="nowrap"><i>(C)</i></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(273,107</td>
<td nowrap="nowrap">)</td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Income from Continuing
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:45px; text-indent:-15px">Operations
Before Income
Taxes
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">428,995</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">408,870</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,202,330</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,151,226</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left">
<div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"> 
</div>
</div>
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
<tr>
<td width="3%"></td>
<td width="1%"></td>
<td width="96"></td>
</tr>
<tr valign="top">
<td nowrap="nowrap" align="left"><i>(A)</i></td>
<td> </td>
<td><i>Intersegment revenues are not material.</i></td>
</tr>
<tr style="font-size: 3pt">
<td> </td>
</tr>
<tr valign="top">
<td nowrap="nowrap" align="left"><i>(B)</i></td>
<td> </td>
<td><i>Includes primarily interest, net; foreign exchange; corporate expenses; and share-based
compensation expense.</i></td>
</tr>
<tr style="font-size: 3pt">
<td> </td>
</tr>
<tr valign="top">
<td nowrap="nowrap" align="left"><i>(C)</i></td>
<td> </td>
<td><i>Includes charge associated with the pending settlement with the direct purchaser plaintiffs
(which includes BD’s distributors) in certain antitrust class actions.</i></td>
</tr>
</table>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Revenues by Organizational Units
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">BD Medical
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Medical Surgical Systems
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">498,872</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">516,024</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,451,954</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,495,553</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Diabetes Care
</div></td>
<td> </td>
<td> </td>
<td align="right">185,851</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">181,713</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">534,249</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">519,314</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Pharmaceutical Systems
</div></td>
<td> </td>
<td> </td>
<td align="right">263,963</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">279,471</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">679,895</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">715,851</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Ophthalmic Systems
</div></td>
<td> </td>
<td> </td>
<td align="right">19,985</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">20,940</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">59,249</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">59,721</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">968,671</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">998,148</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">2,725,347</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">2,790,439</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">BD Diagnostics
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Preanalytical Systems
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">292,187</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">290,761</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">848,806</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">836,422</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Diagnostic Systems
</div></td>
<td> </td>
<td> </td>
<td align="right">274,192</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">262,661</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">797,405</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">770,323</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">566,379</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">553,422</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,646,211</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,606,745</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">BD Biosciences
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Cell Analysis
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">209,769</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">222,075</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">670,283</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">646,909</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Discovery Labware
</div></td>
<td> </td>
<td> </td>
<td align="right">75,436</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">75,694</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">221,300</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">218,693</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">285,205</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">297,769</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">891,583</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">865,602</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">1,820,255</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,849,339</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">5,263,141</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">5,262,786</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 7 - us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 7 — Share-Based Compensation</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company grants share-based awards under the 2004 Employee and Director Equity-Based
Compensation Plan (the “2004 Plan”), which provides long-term incentive compensation to employees
and directors. The Company believes such awards align the interests of its employees and directors
with those of its shareholders.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The fair value of share-based payments is recognized as compensation expense in net income. For
the three months ended June 30, 2009 and 2008, compensation expense charged to income was $22,514
and $22,233, respectively. For the nine months ended June 30, 2009 and 2008, compensation expense
was $78,984 and $80,526, respectively. Share-based compensation attributable to discontinued
operations was not material.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The amount of unrecognized compensation expense for all non-vested share-based awards as of June
30, 2009 was approximately $129,980, which is expected to be recognized over a weighted-average
remaining life of approximately 2.1 years.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The fair values of stock appreciation rights granted during the annual share-based grants in
November of 2008 and 2007, respectively, were estimated on the date of grant using a lattice-based
binomial valuation model based on the following assumptions: risk-free interest rates of 2.73% and
3.83%, respectively; expected volatility of 28% and 27%, respectively; expected dividend yield of
2.11% and 1.35%, respectively; and expected life of 6.5 years for both periods.
</div>
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 8 - bdx:BenefitPlansDisclosureTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 8 — Benefit Plans</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company has defined benefit pension plans covering substantially all of its employees in the
United States and certain foreign locations. The Company also provides certain postretirement
healthcare and life insurance benefits to qualifying domestic retirees. Other postretirement
benefit plans in foreign countries are not material.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Net pension and postretirement cost included the following components for the three months ended
June 30:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">Pension Plans</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">Other Postretirement Benefits</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Service cost
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">13,035</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">16,744</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">865</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,162</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Interest cost
</div></td>
<td> </td>
<td> </td>
<td align="right">21,293</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">20,651</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">3,808</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">3,727</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Expected return on plan assets
</div></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(20,646</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(24,635</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Amortization of prior service cost
</div></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(279</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(288</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(116</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(1,558</td>
<td nowrap="nowrap">)</td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Amortization of loss (gain)
</div></td>
<td> </td>
<td> </td>
<td align="right">4,297</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">2,017</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(36</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">989</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Net pension and postretirement cost
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">17,700</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">14,489</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">4,521</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">4,320</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 6pt">Net pension and postretirement cost included the following components for the nine months
ended June 30:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">Pension Plans</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">Other Postretirement Benefits</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Service cost
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">39,363</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">49,900</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">2,591</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">3,487</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Interest cost
</div></td>
<td> </td>
<td> </td>
<td align="right">64,299</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">61,542</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">11,423</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">11,180</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Expected return on plan assets
</div></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(62,348</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(73,415</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Amortization of prior service cost
</div></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(841</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(858</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(347</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(4,674</td>
<td nowrap="nowrap">)</td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Amortization of loss (gain)
</div></td>
<td> </td>
<td> </td>
<td align="right">12,978</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">6,009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(109</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">3,022</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Settlements
</div></td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">746</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Net pension and postretirement cost
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">53,451</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">43,924</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">13,558</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">13,015</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Postemployment benefit costs for the three months ended June 30, 2009 and 2008 were $4,502 and
$5,941, respectively. For the nine months ended June 30, 2009 and 2008, postemployment benefit
costs were $13,505 and $17,823, respectively.
</div>
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 9 - us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 9 —Divestitures</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">On July 8, 2009, the Company sold certain assets and liabilities related to the elastics and
thermometer components of the Home Healthcare product line of the Medical segment to 3M Company for
$51,022, subject to post-closing adjustments. Concurrent with the sale, the Company intends to
exit the remaining portion of the Home Healthcare product line. The results of operations
associated with the Home Healthcare product line are reported as discontinued operations for all
periods presented in the accompanying Condensed Consolidated Statements of Income. The assets and
liabilities relating to the Home Healthcare product line sale are reported separately as Assets
held for sale and Liabilities held for sale, respectively, in the accompanying Condensed
Consolidated Balance Sheet at June 30, 2009.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Assets held for sale included the following at June 30, 2009:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="88%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Inventory
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">15,265</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Other current assets
</div></td>
<td> </td>
<td> </td>
<td align="right">7,592</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Property, plant and equipment
</div></td>
<td> </td>
<td> </td>
<td align="right">1,374</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Other intangibles, net
</div></td>
<td> </td>
<td> </td>
<td align="right">6,594</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Other assets
</div></td>
<td> </td>
<td> </td>
<td align="right">31</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Assets held for sale
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">30,856</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Liabilities held for sale at June 30, 2009 include Current liabilities of $4,405.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 6pt">Results of discontinued operations were as follows:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Revenues
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">20,798</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">18,687</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">52,214</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">61,895</td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Income from discontinued operations
before income taxes
</div></td>
<td> </td>
<td> </td>
<td align="right">2,537</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">833</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">8,767</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">9,280</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Less income tax provision (benefit)
</div></td>
<td> </td>
<td> </td>
<td align="right">214</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(261</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">1,681</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">1,364</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Income from discontinued
operations, net <i>(A)</i>
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">2,323</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,094</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">7,086</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">7,916</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left">
<div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"> 
</div>
</div>
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
<tr>
<td width="3%"></td>
<td width="1%"></td>
<td width="96"></td>
</tr>
<tr valign="top">
<td nowrap="nowrap" align="left"><i>(A)</i></td>
<td> </td>
<td><i>For the three months ended June 30, 2009 and 2008, includes $(170) and $(320), respectively
associated with the blood glucose monitoring (“BGM”) product line sold in 2006. For the nine
months ended June 30, 2009 and 2008, includes amounts associated with BGM of $(207) and $880,
respectively.</i></td>
</tr>
</table>
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 10 - us-gaap:IntangibleAssetsDisclosureTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 6pt"><u>Note 10 —Intangible Assets</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Intangible assets consisted of:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30, 2009</td>
<td style="border-bottom: 1px solid #000000"> </td>
<td style="border-bottom: 1px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">September 30, 2008</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Gross</td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Gross</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2"> </td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Carrying</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Accumulated</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Carrying</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Accumulated</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Amount</td>
<td style="border-bottom: 1px solid #000000"> </td>
<td style="border-bottom: 1px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Amortization</td>
<td style="border-bottom: 1px solid #000000"> </td>
<td style="border-bottom: 1px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Amount</td>
<td style="border-bottom: 1px solid #000000"> </td>
<td style="border-bottom: 1px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Amortization</td>
<td style="border-bottom: 1px solid #000000"> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Amortized intangible assets
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Core and developed technology
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">515,033</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">209,392</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">548,974</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">200,443</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Patents, trademarks, and other
</div></td>
<td> </td>
<td> </td>
<td align="right">312,117</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">222,074</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">297,321</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">216,697</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">827,150</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">431,466</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">846,295</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">417,140</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Unamortized intangible assets
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Trademarks
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">9,023</td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">9,051</td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Intangible amortization expense for the three months ended June 30, 2009 and 2008 was $11,946
and $12,941, respectively. Intangible amortization expense for the nine months ended June 30, 2009
and 2008 was $35,193 and $37,905, respectively.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 11 - us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 6pt"><u>Note 11 —Derivative Instruments and Hedging Activities</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt"><u><i>Risk Exposures and Hedging Strategies </i></u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company adopted SFAS No. 161 on March 31, 2009. The Statement amends and expands the previous
disclosure requirements of SFAS No. 133. SFAS No. 161 requires qualitative disclosures regarding
how and why an entity uses derivative instruments as well as how these instruments and related
hedged items are accounted for under SFAS No. 133 and its related interpretations. Entities are
also required to provide tabular disclosures that quantify the effects derivative instruments and
hedged items have on financial position, financial performance, and cash flows.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company is exposed to foreign currency exchange risk, interest rate risk and commodity price
risk relating to its ongoing business operations. The Company has foreign currency exposures
throughout Europe, Asia-Pacific, Canada, Japan and Latin America. Transactional currency exposures
that arise from entering into transactions, generally on an intercompany basis, in
non-hyperinflationary countries that are denominated in currencies other than the functional
currency are mitigated primarily through the use of forward contracts and currency options. Hedges
of the transactional foreign exchange exposures resulting primarily from intercompany payables and
receivables do not qualify for hedge accounting under SFAS No. 133.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Currency exposure that arises from translating the worldwide results of operations, specifically
sales, to the U.S. dollar at exchange rates that have fluctuated from the beginning of a reporting
period are partially hedged using option and forward contracts. In accordance with SFAS No. 133,
the Company designates forward and option contracts utilized to hedge these forecasted sales
denominated in foreign currencies as cash flow hedges. The Company’s option contracts expired in
fiscal year 2008 and only forward contracts have been utilized to hedge forecasted sales for fiscal
years 2009 and 2010.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company’s primary interest rate exposure results from changes in short-term U.S. dollar
interest rates. The Company’s policy is to manage interest cost using a mix of fixed and floating
rate debt and it manages debt and interest-bearing investments in tandem, since these items have an
offsetting impact on interest rate exposure. The Company periodically utilizes interest rate swaps
to maintain a balance between fixed and floating rate instruments. Under these interest rate
swaps, the Company exchanges, at specified intervals, the difference between fixed and floating
interest amounts calculated by reference to an agreed-upon notional principal amount. An interest
rate swap currently maintained by the Company to hedge interest costs is designated as a fair value
hedge under SFAS No. 133.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company also manages risks associated with certain forecasted commodity purchases by using
forward contracts. The Company has currently designated a commodity forward contract as a cash
flow hedge of forecasted purchases of polyethylene.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><i>Cash Flow Hedging Strategy</i>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company hedges forecasted sales denominated in foreign currencies using forward and option
contracts to protect against the reduction in value of forecasted foreign currency cash flows
resulting from export sales. The Company’s hedging program has been designed to offset movements
of the U.S. dollar against other foreign currencies and the resulting changes in the present value
of future foreign currency revenue, by either gains or losses in the fair value of foreign currency
derivative contracts. The Company has also entered into a forward contract on ethane to manage the
price risk associated with forecasted purchases of polyethylene used in the Company’s manufacturing
process. The objective of this hedge is to reduce the variability of cash flows associated with
the forecasted purchases of polyethylene.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">Changes in the effective portion of the fair value of the Company’s forward and option contracts
that are designated and qualify as cash flow hedges (i.e., hedging the exposure to variability in
expected future cash flows that is attributable to a particular risk) are included in Other
comprehensive income (loss) until the hedged transactions are reclassified in earnings. Once the
hedged transaction occurs, the gain or loss on the contract is recognized from Accumulated other
comprehensive income (loss) to the same line associated with the forecasted transaction (e.g., in
“Revenues” when the hedged transactions are forecasted sales denominated in foreign currencies, in
“Cost of products sold” when hedged transactions are forecasted commodity purchases). The Company
records the premium or discount of the forward contracts, which is included in the assessment of
hedge effectiveness, to Revenues. At June 30, 2009, the Company expects to reclassify $11,400, net
of tax, of net losses on foreign currency exchange instruments from Accumulated other comprehensive
income to earnings during the next 12 months due to actual and forecasted export sales. This net
loss is comprised of a gain of $8,271, net of tax, which will be reclassified to earnings in the
fourth quarter of 2009, and a loss of $19,671, net of tax, which will be reclassified to earnings
in the first nine months of 2010. At June 30, 2009, the expected reclassification of net losses on
the ethane forward contract from Accumulated other comprehensive income to Cost of products sold
during the next 12 months is $60.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company’s policy is to manage interest cost using a mix of fixed and floating rate debt.
Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging
the exposure to variability in expected future cash flows that is attributable to a particular
risk) under SFAS No. 133 are offset by amounts recorded in other comprehensive income (loss). If
interest rate derivatives designated as cash flow hedges are terminated, the balance in other
comprehensive income (loss) attributable to those derivatives is reclassified into earnings over
the remaining life of the hedged debt. The Company currently has no active or “live” interest rate
swaps designated as cash flow hedges under SFAS No. 133. The amounts, related to terminated
interest rate swaps, that will be reclassified and recorded in Interest expense within the next 12
months is $1,235, net of tax.
</div>
<div align="left" style="font-size: 10pt; margin-top: 12pt"><i>Fair Value Hedging Strategy</i>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to
changes in the fair value of an asset or a liability or an identified portion thereof that is
attributable to a particular risk), changes in the fair value of the interest rate swaps offset
changes in the fair value of the fixed rate debt due to changes in market interest rates. The
Company currently has one active or “live” interest rate swap that is classified as a fair value
hedge under SFAS No. 133.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><i>Volume of Derivative Activity</i>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The total notional amount of the Company’s outstanding foreign exchange contracts as of June 30,
2009 was $2,026,243. As of June 30, 2009, the notional amount of the Company’s commodity contract
was 824,000 gallons of ethane. As of June 30, 2009 the total notional amount of the Company’s
outstanding interest rate swaps was $200,000.
</div>
<div align="left" style="font-size: 10pt; margin-top: 12pt"><i>Risk Exposures Not Hedged</i>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company purchases resins, which are oil-based components used in the manufacture of certain
products. While the Company has been able to hedge certain purchases of polyethylene, the Company
does not currently utilize any hedges to manage the risk exposures related to other resins.
Significant increases in world oil prices that lead to increases in resin purchase costs could
impact future operating results.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt"><u><i>Effects on Consolidated Balance Sheets</i></u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The location and amounts of derivative instrument fair values in the consolidated balance sheet are
segregated below between designated, qualifying SFAS No. 133 hedging instruments and ones that are
not designated under SFAS No. 133 for hedge accounting.
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="76%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">September 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">2008</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Fair Value</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Fair Value</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Asset derivatives-designated under SFAS No. 133
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Forward exchange contracts
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">14,480</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">61,906</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Interest rate swap
</div></td>
<td> </td>
<td> </td>
<td align="right">2,477</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">5,372</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Total asset derivatives-designated under SFAS No. 133
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">16,957</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">67,278</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Asset derivatives-undesignated under SFAS No. 133
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Forward exchange contracts
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">11,476</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">16,431</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Total asset derivatives <i>(A)</i>
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">28,433</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">83,709</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Liability derivatives-designated under SFAS No. 133
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Forward exchange contracts
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">38,418</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">961</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Commodity forward contracts
</div></td>
<td> </td>
<td> </td>
<td align="right">40</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Total liability derivatives-designated under SFAS No. 133
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">38,458</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">961</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Liability derivatives-undesignated under SFAS No. 133
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Forward exchange contracts
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">12,950</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">28,686</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom"><!-- Blank Space -->
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Total liability derivatives <i>(B)</i>
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">51,408</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">29,647</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left">
<div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"> 
</div>
</div>
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
<tr>
<td width="3%"></td>
<td width="1%"></td>
<td width="96"></td>
</tr>
<tr valign="top">
<td nowrap="nowrap" align="left"><i>(A)</i></td>
<td> </td>
<td><i>All asset derivatives are included in Prepaid expenses, deferred taxes and other.</i></td>
</tr>
<tr style="font-size: 3pt">
<td> </td>
</tr>
<tr valign="top">
<td nowrap="nowrap" align="left"><i>(B)</i></td>
<td> </td>
<td><i>All liability derivatives are included in Payables and accrued expenses.</i></td>
</tr>
</table>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
<tr>
<td width="3%"></td>
<td width="1%"></td>
<td width="96"></td>
</tr>
<tr valign="top">
<td colspan="3"><u><i>Effects on Consolidated Statements of Income</i></u></td>
</tr>
</table>
<div align="left" style="font-size: 10pt; margin-top: 6pt"><i>Cash flow hedges</i>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The location and amount of gains and losses on designated, qualifying SFAS No. 133 derivative
instruments recognized in the consolidated statement of income for the three months ended June 30
consisted of:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="35%"> </td>
<td width="3%"> </td>
<td width="4%"> </td>
<td width="1%"> </td>
<td width="4%"> </td>
<td width="3%"> </td>
<td width="2%"> </td>
<td width="1%"> </td>
<td width="2%"> </td>
<td width="3%"> </td>
<td width="22%"> </td>
<td width="3%"> </td>
<td width="2%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="3%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="4%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Gain (Loss)</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Reclassified from</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Gain (Loss) Recognized</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center"> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Accumulated OCI into</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">in OCI on Derivatives</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center">Location of Gain (Loss)</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">Income</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center">Derivatives in SFAS No. 133 </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center">Reclassified from</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center">Cash Flow Hedging </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center">Accumulated OCI into</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center" style="border-bottom: 1px solid #000000">Relationships </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" style="border-bottom: 1px solid #000000">Income</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Forward exchange contracts
</div></td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(43,759</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td align="left">$</td>
<td align="right">5,319</td>
<td> </td>
<td>    </td>
<td align="left" valign="top">Revenues</td>
<td> </td>
<td align="left">$</td>
<td align="right">27,766</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Currency options
</div></td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">1,312</td>
<td> </td>
<td> </td>
<td align="left" valign="top">Revenues</td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(2,874</td>
<td nowrap="nowrap">)</td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Interest rate swaps
</div></td>
<td> </td>
<td> </td>
<td align="right">274</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">273</td>
<td> </td>
<td> </td>
<td align="left" valign="top">Interest expense</td>
<td> </td>
<td> </td>
<td align="right">274</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">273</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Commodity forward contracts
</div></td>
<td> </td>
<td> </td>
<td align="right">155</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td align="left" valign="top">Cost of products sold</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(107</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td align="left" valign="top"> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Total
</div></td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(43,330</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td align="left">$</td>
<td align="right">6,904</td>
<td> </td>
<td> </td>
<td align="left" valign="top"> </td>
<td> </td>
<td align="left">$</td>
<td align="right">27,933</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(2,601</td>
<td nowrap="nowrap">)</td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td align="left" valign="top"> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The location and amount of gains and losses on designated, qualifying SFAS No. 133 derivative
instruments recognized in the consolidated statement of income for the nine months ended June 30
consisted of:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="35%"> </td>
<td width="3%"> </td>
<td width="4%"> </td>
<td width="1%"> </td>
<td width="4%"> </td>
<td width="3%"> </td>
<td width="2%"> </td>
<td width="1%"> </td>
<td width="2%"> </td>
<td width="3%"> </td>
<td width="22%"> </td>
<td width="3%"> </td>
<td width="2%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="3%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="4%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Gain (Loss)</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Reclassified from</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Gain (Loss) Recognized</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center"></td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Accumulated OCI into</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">in OCI on Derivatives</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center">Location of Gain (Loss)</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">Income</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center">Derivatives in SFAS No. 133</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended June</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center">Reclassified from</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center">Cash Flow Hedging</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center">Accumulated OCI into</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center" style="border-bottom: 1px solid #000000">Relationships</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" style="border-bottom: 1px solid #000000">Income</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Forward exchange contracts
</div></td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(49,187</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td align="left">$</td>
<td align="right">5,319</td>
<td> </td>
<td>    </td>
<td align="left" valign="top">Revenues</td>
<td> </td>
<td align="left">$</td>
<td align="right">93,567</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Currency options
</div></td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">2,559</td>
<td> </td>
<td> </td>
<td align="left" valign="top">Revenues</td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(7,287</td>
<td nowrap="nowrap">)</td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Interest rate swaps
</div></td>
<td> </td>
<td> </td>
<td align="right">820</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">818</td>
<td> </td>
<td> </td>
<td align="left" valign="top">Interest expense</td>
<td> </td>
<td> </td>
<td align="right">820</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">818</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Commodity forward contracts
</div></td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(60</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td align="left" valign="top">Cost of products sold</td>
<td> </td>
<td nowrap="nowrap" align="left"> </td>
<td align="right">(169</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td align="left" valign="top"> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Total
</div></td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(48,427</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td align="left">$</td>
<td align="right">8,696</td>
<td> </td>
<td> </td>
<td align="left" valign="top"> </td>
<td> </td>
<td align="left">$</td>
<td align="right">94,218</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(6,469</td>
<td nowrap="nowrap">)</td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td align="left" valign="top"> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company’s designated SFAS No. 133 derivative instruments are perfectly effective. As
such, there were no gains or losses, related to hedge ineffectiveness or amounts excluded from
hedge effectiveness testing, recognized immediately in income for the three-month and nine-month
periods ending June 30, 2009.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><i>Fair value hedge</i>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The location and amount of gains or losses on the hedged fixed rate debt attributable to changes in
the market interest rates and the offsetting gain (loss) on the related interest rate swap are as
follows:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="20%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="14" style="border-bottom: 1px solid #000000">Gain/(Loss) on Swap</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="14" style="border-bottom: 1px solid #000000">Gain/(Loss) on Borrowings</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center">Income Statement </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td style="border-bottom: 0px solid #000000"> </td>
<td style="border-bottom: 0px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center" style="border-bottom: 1px solid #000000">Classification</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td style="border-bottom: 0px solid #000000"> </td>
<td style="border-bottom: 0px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td style="border-bottom: 0px solid #000000"> </td>
<td style="border-bottom: 0px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td style="border-bottom: 0px solid #000000"> </td>
<td style="border-bottom: 0px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td style="border-bottom: 0px solid #000000"> </td>
<td style="border-bottom: 0px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td style="border-bottom: 0px solid #000000"> </td>
<td style="border-bottom: 0px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td style="border-bottom: 0px solid #000000"> </td>
<td style="border-bottom: 0px solid #000000"> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td style="border-bottom: 0px solid #000000"> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Other (expense)
income <i>(A)</i>
</div></td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(2,105</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(4,900</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(2,896</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(159</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td align="left">$</td>
<td align="right">2,105</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">4,900</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">2,896</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">159</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left">
<div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"> 
</div>
</div>
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
<tr>
<td width="3%"></td>
<td width="1%"></td>
<td width="96"></td>
</tr>
<tr valign="top">
<td nowrap="nowrap" align="left"><i>(A)</i></td>
<td> </td>
<td><i>Changes in the fair value of the interest rate swap offset changes in the fair value of
the fixed rate debt due to changes in market interest rates. There was no hedge
ineffectiveness relating to this interest rate swap.</i></td>
</tr>
</table>
<div align="left" style="font-size: 10pt; margin-top: 12pt"><i>Undesignated hedges</i>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The location and amount of gains and losses recognized in income on derivatives not designated as
hedging instruments under SFAS No. 133 were as follows:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="36%"> </td>
<td width="3%"> </td>
<td width="23%"> </td>
<td width="3%"> </td>
<td width="4%"> </td>
<td width="1%"> </td>
<td width="4%"> </td>
<td width="3%"> </td>
<td width="2%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
<td width="3%"> </td>
<td width="2%"> </td>
<td width="1%"> </td>
<td width="2%"> </td>
<td width="3%"> </td>
<td width="2%"> </td>
<td width="1%"> </td>
<td width="3%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="14" style="border-bottom: 1px solid #000000">Amount of Gain (Loss) Recognized in Income on Derivative</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center">Derivatives Not Designated as</td>
<td> </td>
<td nowrap="nowrap" align="center">Location of Gain (Loss)</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center">Hedging Instruments Under</td>
<td> </td>
<td nowrap="nowrap" align="center">Recognized in Income on</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="6" style="border-bottom: 1px solid #000000">June 30,</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td nowrap="nowrap" align="center" style="border-bottom: 1px solid #000000">SFAS No. 133 </td>
<td> </td>
<td nowrap="nowrap" align="center" style="border-bottom: 1px solid #000000">Derivatives</td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2009</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom">
<td>
<div style="margin-left:15px; text-indent:-15px">Forward exchange contracts <i>(B)</i>
</div></td>
<td> </td>
<td align="left" valign="top">Other (expense) income</td>
<td> </td>
<td nowrap="nowrap" align="left">$</td>
<td align="right">(21,868</td>
<td nowrap="nowrap">)</td>
<td> </td>
<td align="left">$</td>
<td align="right">14,505</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">3,007</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">35,004</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td align="left" valign="top"> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left">
<div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"> 
</div>
</div>
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
<tr>
<td width="3%"></td>
<td width="1%"></td>
<td width="96"></td>
</tr>
<tr valign="top">
<td nowrap="nowrap" align="left"><i>(B)</i></td>
<td> </td>
<td><i>The gains and losses on forward contracts and currency options utilized to hedge the
intercompany transactional foreign exchange exposures are largely offset by gains and
losses on the underlying hedged items in Other (expense) income.</i></td>
</tr>
</table>
</div>
</body>
</html>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<html>
<head></head>
<body>
<!-- Begin Block Tagged Note 12 - us-gaap:FairValueDisclosuresTextBlock-->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 12pt"><u>Note 12 —Financial Instruments and Fair Value Measurements</u>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company adopted SFAS No. 157 for financial assets and liabilities on October 1, 2008. The
provisions of SFAS No. 157 define fair value as the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the
measurement date. SFAS No. 157 requires the categorization of assets and liabilities within a
three-level hierarchy based upon inputs used in measuring fair value. The Company adopted FSP
107-1 on June 30, 2009. This FSP amends SFAS No. 107 to require disclosure about fair value of
financial instruments, including those not recognized on the statement of financial position at
fair value, for interim reporting periods as well as in annual financial statements.
</div>
<!-- Folio -->
<!-- /Folio -->
</div>
<!-- PAGEBREAK -->
<div style="font-family: 'Times New Roman',Times,serif">
<div align="left" style="font-size: 10pt; margin-top: 6pt">The fair values of financial instruments carried at June 30, 2009 are classified in accordance with
the SFAS No. 157 fair value hierarchy in the table below:
</div>
<div align="center">
<table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<tr valign="bottom">
<td width="52%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
<td width="5%"> </td>
<td width="1%"> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="10" style="border-bottom: 1px solid #000000">Basis of Fair Value Measurement</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Quoted Prices</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2"> </td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">in Active</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Significant</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2"> </td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Markets for</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Other</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Significant</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Carrying</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Identical Assets</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Observable</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2">Unobservable</td>
<td> </td>
</tr>
<tr style="font-size: 8pt" valign="bottom">
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Value</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">(Level 1)</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Inputs (Level 2)</td>
<td> </td>
<td> </td>
<td nowrap="nowrap" align="center" colspan="2" style="border-bottom: 1px solid #000000">Inputs (Level 3)</td>
<td> </td>
</tr>
<!-- End Table Head -->
<!-- Begin Table Body -->
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Assets
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Cash and equivalents
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">573,259</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">573,259</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Forward exchange contracts
</div></td>
<td> </td>
<td align="left"> </td>
<td align="right">25,956</td>
<td> </td>
<td> </td>
<td align="left"> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td align="left"> </td>
<td align="right">25,956</td>
<td> </td>
<td> </td>
<td align="left"> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Interest rate swap
</div></td>
<td> </td>
<td> </td>
<td align="right">2,477</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">2,477</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Equity securities
</div></td>
<td> </td>
<td> </td>
<td align="right">98</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">98</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:30px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:45px; text-indent:-15px">Total Assets
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">601,790</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">573,357</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">28,433</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:15px; text-indent:-15px">Liabilities
</div></td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Forward exchange contracts
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">51,368</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">51,368</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:30px; text-indent:-15px">Commodity forward contracts
</div></td>
<td> </td>
<td> </td>
<td align="right">40</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">40</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr valign="bottom">
<td>
<div style="margin-left:30px; text-indent:-15px">Long-term debt
</div></td>
<td> </td>
<td> </td>
<td align="right">1,483,560</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">1,552,598</td>
<td> </td>
<td> </td>
<td> </td>
<td align="right">—</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:30px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td>
<td> </td>
</tr>
<tr valign="bottom" style="background: #cceeff">
<td>
<div style="margin-left:45px; text-indent:-15px">Total Liabilities
</div></td>
<td> </td>
<td align="left">$</td>
<td align="right">1,534,968</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">1,604,006</td>
<td> </td>
<td> </td>
<td align="left">$</td>
<td align="right">—</td>
<td> </td>
</tr>
<tr style="font-size: 1px">
<td>
<div style="margin-left:15px; text-indent:-15px"> 
</div></td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
<td> </td>
<td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td>
<td> </td>
</tr>
<!-- End Table Body -->
</table>
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">The Company’s cash and equivalents include money market fund balances. The fair values of
these investments are based upon the quoted prices provided by the holding financial institutions.
The Company’s remaining cash equivalents and short-term investments are carried at cost, which
approximates fair value. The Company measures the fair value of forward exchange contracts and
currency options based upon observable inputs, specifically spot currency rates and forward
currency prices for similar assets and liabilities. The fair value of forward commodity contracts
and interest rate swaps are provided by the financial institutions that are counterparties to these
arrangements. Equity securities are valued using unadjusted quoted prices from active markets,
such as stock exchanges, with frequent transactions and sufficient volume to provide pricing on an
ongoing basis. The fair value of long-term debt is based upon quoted prices in active markets for
similar instruments.
</div>
<div align="left" style="font-size: 10pt; margin-top: 6pt">In May 2009, the Company issued $500,000 of 10-year 5% notes and $250,000 of 30-year 6% notes. The
net proceeds from these issuances are expected to be used for the repayment of $200,000 in 7.15%
notes, due October 1, 2009, and for general corporate purposes.
</div>
</div>
</body>
</html>
348531000
305641000
32489000
10956000
18730000
12767000
464982000
383032000
89675000
99066000
287169000
99928000
294391000
98489000
false
--09-30
2009-06-30
10-Q
0000010795
239389718
Yes
Large Accelerated Filer
20897758525
BECTON, DICKINSON AND COMPANY
No
Yes
1079051000
1144944000
1215267000
1236320000
3053521000
3196140000
-77510000
-220297000
1359531000
1465823000
7912943000
8848987000
3614675000
4491537000
0
30856000
133486000
175991000
-31009000
-81183000
511482000
735908000
830477000
1331601000
224426000
501124000
-286000
-127000
24857000
9778000
0.855
0.285
0.99
0.33
-14694000
-17146000
332662000
332662000
2566465000
905388000
2485687000
860063000
4116846000
1441123000
4052396000
1388492000
201312000
405737000
-10766000
-21627000
352936000
352246000
3.46
1.22
3.8
1.42
3.34
1.18
3.7
1.39
12882000
-4740000
55715000
12170000
625768000
610782000
836905000
295995000
907297000
338704000
1151226000
408870000
1202330000
428995000
3.42
1.21
3.77
1.41
3.31
1.18
3.67
1.38
7916000
1094000
7086000
2323000
0.03
0
0.03
0.01
0.03
0
0.03
0.01
314321000
112875000
295033000
90291000
-84742000
-214969000
19863000
22126000
10582000
-75909000
27455000
9017000
26607000
11288000
713774000
810931000
1080426000
1207007000
162726000
171258000
203926000
224818000
7912943000
8848987000
1416579000
1646462000
0
4405000
953226000
1483560000
24571000
9651000
-447970000
162014000
-570361000
-713949000
1205304000
1048148000
844821000
297089000
914383000
341027000
1145940000
408216000
1210745000
431763000
424779000
356770000
356334000
383469000
142588000
124037000
252000
-1285000
-538000
-4247000
199942000
420359000
50170000
223064000
29663000
55634000
354389000
371426000
208996000
237908000
41394000
0
418125000
354068000
0
736207000
64031000
21655000
-3740000
1605000
5797995000
5978641000
2744474000
2782501000
591000
289000
6838589000
7514585000
5262786000
1849339000
5263141000
1820255000
1263212000
435807000
1272318000
429940000
80526000
78984000
4935568000
5211896000
3532398000
3898023000
Total per share amounts may not add due to rounding.